Key topics and trends for pharma and healthcare in 2016
Introducing PERSPECTIVE, the new digital magazine from Blue Latitude Health. A step beyond identifying top trends, this magazine explores key topics for 2016 for pharma and healthcare companies.
Welcome to the first issue of PERSPECTIVE, the Blue Latitude Health magazine
Stay on top of the changes and shifts in the industry
A step beyond identifying top trends, this magazine explores key topics for 2016:
Getting beyond the patient journey to better understand customer needs
What you need to know about genomic data to stay ahead of the curve
How to mature your approach to Content Strategy
The evolution of brand teams and what that means for your business
How to adapt to healthcare disruption by tangibly defining the value of services
The paradigm in healthcare and pharma is shifting, and brands must be engaged with that shift. In creating this magazine, we hope that together, we can help you push your thinking forward.
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies can position themselves as leaders at the forefront of these exciting innovations. Blue Latitude Health
The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these tools by healthcare professionals is comparatively low. Senior User Experience Consultant Stewart Anderson explains why. Blue Latitude Health
In this special pack, we provide a comprehensive outlook of launch excellence. We cover topics ranging from gathering effective insights, to understanding the current landscape, and the importance of pre-launch strategy for improving relationships between the customer and the brand. Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines. Blue Latitude Health
In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in development. So how can pharma ensure its product stands out from the crowd? Blue Latitude Health
Pharmaceutical launches are becoming more complex and competitive. Our launch excellence diagnostic tool helps you to map how ready you are for launch, while facilitating success in this challenging environment. Blue Latitude Health